| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 17, 2019 | 28.00 | 28.70 | 27.50 | 28.05 | 154,242 |
| May 16, 2019 | 28.50 | 28.84 | 28.06 | 28.10 | 20,374,881 |
| May 15, 2019 | 27.70 | 28.80 | 27.60 | 28.70 | 291,680 |
| May 14, 2019 | 26.90 | 27.65 | 26.90 | 27.65 | 86,535 |
| May 13, 2019 | 28.00 | 29.40 | 26.00 | 27.45 | 388,011 |
| Name | Circassia Pharmaceuticals | Epic | CIR |
|---|---|---|---|
| ISIN | GB00BJVD3B28 | Currency | GBX |
| Type | Equity | Trading Segment | AMSM |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Biotechnology |
| EMS | 10,000 | Prev Close | 28.05 |
| Shares in Issue (m) | 375.05 | Market Cap (£m) | 105.39 |
| PE Ratio | -0.83 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -34.00 | EPS Growth (%) | -9.68 |
| PEG | 0.09 | DPS Growth (%) | n/a |
| ROCE | -30.49 | Net Gearing | 45.80 |
| Quick Ratio | 0.40 | Current Ratio | 0.43 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 08 May | Peel Hunt | Buy | 28.05 | 90.00 | - | Reiterates |
| 02 May | Peel Hunt | Buy | 28.05 | 90.00 | - | Reiterates |
| 01 May | Numis | Buy | 28.05 | 110.00 | - | Reiterates |
| 01 May | Peel Hunt | Buy | 28.05 | 90.00 | - | Reiterates |
| 23 Apr | Peel Hunt | Buy | 28.05 | 90.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 17 Jul 2017 | Steven Harris | Exercise | 535,375 @ 0.08p | £428.30 |
| 18 Sep 2015 | Charles Swingland | Sell | 1,230,000 @ 318.24p | £3,914,352.00 |
| 18 Sep 2015 | Charles Swingland | Sell | 9,000 @ 318.72p | £28,684.80 |
| 18 Sep 2015 | Charles Swingland | Sell | 754,548 @ 320.24p | £2,416,364.52 |
| 27 Mar 2014 | Dr Rod Hafner | Exercise | 212,375 @ 0.08p | £169.90 |
